Essex Investment Management’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-40,828
| Closed | -$190K | – | 517 |
|
|
2020
Q2 | $190K | Sell |
40,828
-24,600
| -38% | -$114K | 0.03% | 315 |
|
|
2020
Q1 | $339K | Sell |
65,428
-1,515
| -2% | -$7.85K | 0.07% | 248 |
|
|
2019
Q4 | $335K | Buy |
66,943
+2,366
| +4% | +$11.8K | 0.04% | 345 |
|
|
2019
Q3 | $513K | Hold |
64,577
| – | – | 0.07% | 288 |
|
|
2019
Q2 | $468K | Buy |
64,577
+27,416
| +74% | +$199K | 0.06% | 308 |
|
|
2019
Q1 | $297K | Buy |
37,161
+3,193
| +9% | +$25.5K | 0.04% | 308 |
|
|
2018
Q4 | $272K | Buy |
33,968
+3,751
| +12% | +$30K | 0.04% | 301 |
|
|
2018
Q3 | $465K | Buy |
+30,217
| New | +$465K | 0.05% | 302 |
|